Autologous EBV-Transformed B Lymphoblastoid-Tumor Fusion Cell Vaccine

**Semantic type:** Immunologic Factor|Pharmacologic Substance

**Definition:** A cell-based vaccine composed of autologous tumor cells fused with Epstein-Barr virus-transformed B-lymphoblastoid cells. Upon administration, this vaccine may stimulate a cytotoxic T cell response against tumor cells, resulting in tumor cell lysis. (NCI05)